Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to recent Securities and Exchange Commission filings. The transactions ...

Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The ...

A very well-timed investment into a medical AI company has more than doubled Pelosi's investment in just three weeks.

CHICAGO—Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), has recently sold a significant portion of his holdings in the company. According to a filing with the Securities and ...

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Let's explore the Tempus AI stock price and whether it is a good company to buy and hold despite its overvaluation.

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

Tempus Wealth Planning LLC raised its stake in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) by 1.7% during the fourth ...

With a volume of 14,494,605, the price of TEM is up 2.62% at $66.69. RSI indicators hint that the underlying stock may be overbought. Next earnings are expected to be released in 14 days.